Dehydroemetine dosage and administration: Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Dehydroemetine}} {{CMG}} <ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: P...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Dosage and Administration== | |||
Adults: 1 mg/kg daily, to a maximum of 60 mg, for up to 4-6 days. This dosage should be reduced by up to 50% in elderly and severely ill patients. | |||
<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.3.html#Jh2922e.2.1.3 | publisher = | date = | accessdate = }}</ref> | Children: 1 mg/kg daily for no more than 5 days. | ||
Injections should always be given intramuscularly. Intravenous injection is unacceptably dangerous and holds no advantage. At least 6 weeks should elapse before a second course is administered. | |||
In amoebic dysentery, supplementary treatment with tetracycline reduces the risk of bacterial superinfection. | |||
In hepatic abscess, supplementary treatment with chloroquine, which is selectively concentrated in the liver, may be given orally, either concurrently or immediately afterwards. | |||
All patients should subsequently receive diloxanide by mouth to eliminate surviving organisms in the colon.<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.3.html#Jh2922e.2.1.3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 00:35, 31 December 2013
| Dehydroemetine |
|---|
| MEBADIN® Prescribing Information |
| General Information |
| Clinical Information |
| Dosage and Administration |
| Precautions |
| Use in Pregnancy |
| Adverse Effects |
| Drug Interactions |
| Storage |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosage and Administration
Adults: 1 mg/kg daily, to a maximum of 60 mg, for up to 4-6 days. This dosage should be reduced by up to 50% in elderly and severely ill patients.
Children: 1 mg/kg daily for no more than 5 days.
Injections should always be given intramuscularly. Intravenous injection is unacceptably dangerous and holds no advantage. At least 6 weeks should elapse before a second course is administered.
In amoebic dysentery, supplementary treatment with tetracycline reduces the risk of bacterial superinfection.
In hepatic abscess, supplementary treatment with chloroquine, which is selectively concentrated in the liver, may be given orally, either concurrently or immediately afterwards.
All patients should subsequently receive diloxanide by mouth to eliminate surviving organisms in the colon.[1]